Our human hemolyzed plasma is prepared from plasma intentionally subjected to controlled red blood cell lysis, providing a reliable matrix for interference testing, assay validation, and analytical method development. The presence of free hemoglobin mimics hemolytic conditions observed in clinical samples, making this plasma ideal for evaluating test robustness and detecting hemolysis-related bias.
Available at defined hemolysis levels (1%, 2%, and 5%), this product supports a wide range of diagnostic, pharmacokinetic, and analytical applications. Each lot is processed under controlled conditions to ensure reproducibility and consistency.
Human Hemolyzed Plasma
Hemolysis Level - 1%, 2% or 5%
Hemoglobin concentration
Diagnostic assay interference testing
Method validation and robustness assessment
Pharmacokinetic and bioanalytical studies
Research involving hemolysis-related conditions